Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Heinz Schmidli"'
Publikováno v:
Journal of Statistical Software, Vol 100, Pp 1-32 (2021)
Use of historical data in clinical trial design and analysis has shown various advantages such as reduction of number of subjects and increase of study power. The metaanalytic-predictive (MAP) approach accounts with a hierarchical model for between-t
Externí odkaz:
https://doaj.org/article/69c05d11bda5431eb8eb6654b602e961
Autor:
Mouna Akacha, Christian Bartels, Björn Bornkamp, Frank Bretz, Neva Coello, Thomas Dumortier, Michael Looby, Oliver Sander, Heinz Schmidli, Jean‐Louis Steimer, Camille Vong
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 4, Pp 279-282 (2021)
Externí odkaz:
https://doaj.org/article/3b8ad428c84940ed841522ba4471f1f8
Autor:
Jennifer S. Graves, Marius Thomas, Jun Li, Anuja R. Shah, Alexandra Goodyear, Markus R. Lange, Heinz Schmidli, Dieter A. Häring, Tim Friede, Jutta Gärtner
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 15 (2022)
Background: To support innovative trial designs in a regulatory setting for pediatric-onset multiple sclerosis (MS), the study aimed to perform a systematic literature review and meta-analysis of relapse rates with interferon β (IFN β), fingolimod,
Externí odkaz:
https://doaj.org/article/3280060de3e7485a9ca98c0a21cbc0c6
Publikováno v:
Biometrics.
Publikováno v:
Statistics in Biopharmaceutical Research. 15:238-248
Treatment effects on recurrent events are of primary clinical interest in many diseases such as asthma, multiple sclerosis or chronic heart failure. When death makes it impossible to experience fur...
Autor:
Frank Bretz, Marius Thomas, Sebastian Weber, Dieter A. Häring, Heinz Schmidli, Adrian Cassidy
Publikováno v:
Clinical Pharmacology & Therapeutics. 107:806-816
Randomized controlled trials are the gold standard to investigate efficacy and safety of new treatments. In certain settings, however, randomizing patients to control may be difficult for ethical or feasibility reasons. Borrowing strength using relev
Publikováno v:
Handbook of Statistical Methods for Randomized Controlled Trials ISBN: 9781315119694
Handbook of Statistical Methods for Randomized Controlled Trials
Handbook of Statistical Methods for Randomized Controlled Trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b46f3a87408d5b256b7f557672b39dc5
https://doi.org/10.1201/9781315119694-25
https://doi.org/10.1201/9781315119694-25
Publikováno v:
63. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS); 20180902-20180906; Osnabrück; DOCAbstr. 281 /20180827/
In some diseases, such as multiple sclerosis, lesion counts obtained from magnetic resonance imaging (MRI) are used as markers of disease progression. This leads to longitudinal, and typically overdispersed, count data outcomes in clinical trials. Mo
Autor:
Christian Röver, Ralf Bender, Sebastian Weber, Tim Friede, Christopher H. Schmid, Sofia Dias, Sibylle Sturtz, Heinz Schmidli
The normal-normal hierarchical model (NNHM) constitutes a simple and widely used framework for meta-analysis. In the common case of only few studies contributing to the meta-analysis, standard approaches to inference tend to perform poorly, and Bayes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f183c998045fca5c84830fe5c4a651
https://eprints.whiterose.ac.uk/170174/7/jrsm.1475.pdf
https://eprints.whiterose.ac.uk/170174/7/jrsm.1475.pdf
Autor:
Camille Vong, Frank Bretz, Thomas Dumortier, Jean-Louis Steimer, Heinz Schmidli, Oliver Sander, Christian Bartels, Neva Coello, Michael Looby, Björn Bornkamp, Mouna Akacha
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 4, Pp 279-282 (2021)
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 4, Pp 279-282 (2021)